Scientific Opinion on the substantiation of a health claim related to Vichy Catalan carbonated natural mineral water and reduction of post-prandial lipaemic response pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Tabs

Article
Vichy Catalan, mineral water, triglycerides, lipaemic response, health claims
First published in the EFSA Journal
12. Februar 2013
Adopted
24. Januar 2013
Type
Opinion of the Scientific Committee/Scientific Panel
Abstract

Following an application from S.A. Vichy Catalan, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Spain, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vichy Catalan carbonated natural mineral water and reduction of post-prandial lipaemic response. The food, Vichy Catalan carbonated natural mineral water, that is the subject of the health claim is sufficiently characterised. The claimed effect, reduction of post-prandial lipaemic response, is a beneficial physiological effect. In weighing the evidence, the Panel took into account that the results of the only study from which conclusions could be drawn for the scientific substantiation of the claim do not support an effect of Vichy Catalan carbonated natural mineral water on the reduction of post-prandial lipaemic response. A cause and effect relationship has not been established between the consumption of Vichy Catalan carbonated natural mineral water and reduction of post-prandial lipaemic response.

Panel members at the time of adoption
Carlo Agostoni, Roberto Berni Canani, Susan Fairweather-Tait, Marina Heinonen, Hannu Korhonen, Sébastien La Vieille, Rosangela Marchelli, Ambroise Martin, Androniki Naska, Monika Neuhäuser-Berthold, Grażyna Nowicka, Yolanda Sanz, Alfonso Siani, Anders Sjödin, Martin Stern, Sean (J.J.) Strain, Inge Tetens, Daniel Tomé, Dominique Turck and Hans Verhagen.
Panel on Dietetic Products, Nutrition and Allergies
Contact
nda [at] efsa.europa.eu
doi
10.2903/j.efsa.2013.3087
EFSA Journal 2013;11(2):3087 [12 pp.].
Question Number
On request from
the Competent Authority of Spain following an application by S.A. Vichy Catalan
Print on demand
Number of Pages
12